Rockwell Medical (RMTI) Operating Income (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Operating Income came in at -$1.5 million in Q1 2026, down 8.82% YoY from -$1.6 million in Q1 2025, and down 271.86% on a QoQ basis from -$398000.0 in Q4 2025.
Rockwell Medical (RMTI) Operating Income (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Operating Income data on file, last reported at -$1.5 million in Q1 2026.
- Quarterly Operating Income fell 8.82% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (down 941.08% YoY) and the FY2025 annual result came in at -$4.7 million, down 871.55% from the prior year.
- Operating Income declined to -$1.5 million in Q1 2026, from -$398000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $1.9 million in Q3 2024 to a low of -$6.6 million in Q1 2022.
- A 5-year average of -$1.7 million and a median of -$1.4 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income jumped 211.46% — and 2025, when it tumbled 361.94%.
- Tracing RMTI's Operating Income over 5 years: stood at -$2.0 million in 2022, then soared by 72.18% to -$547000.0 in 2023, then grew by 5.12% to -$519000.0 in 2024, then gained by 23.31% to -$398000.0 in 2025, then tumbled by 271.86% to -$1.5 million in 2026.
- The last three Operating Income figures came in at -$1.5 million (Q1 2026), -$398000.0 (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn | -1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.06 Mn |
| Mar 31, 2026 | -1.48 Mn |
| Dec 31, 2025 | -398,000.00 |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | -519,000.00 |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 515,000.00 |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | -547,000.00 |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -2.96 Mn |
| Mar 31, 2023 | -1.43 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | -3.71 Mn |
| Jun 30, 2022 | -4.48 Mn |
| Mar 31, 2022 | -6.63 Mn |
| Dec 31, 2021 | -8.36 Mn |
| Sep 30, 2021 | -6.97 Mn |